
Sign up to save your podcasts
Or


In today’s healthcare-focused episode of Where The Money Is, Motley Fool analysts David Williamson and Michael Douglass talk about an exciting new study on medical marijuana and a big biotech buyout.
By The Motley Fool
In today’s healthcare-focused episode of Where The Money Is, Motley Fool analysts David Williamson and Michael Douglass talk about an exciting new study on medical marijuana and a big biotech buyout.